Intas partners with IntegriMedical for needle-free injection system in IVF & gynecology. Aims to improve patient experience and reduce anxiety.

Intas Pharmaceuticals on Monday said it has tied up with IntegriMedical to introduce a needle free injection system for use in IVF and gynecology treatments. As part of the agreement, Intas has become ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...

When the Trump administration slashed foreign aid, it gutted a program that had reduced malaria deaths world wide. In ...

The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...

Therefore, the ideal candidates for a spinal injection are those with symptoms (sciatica) that are predominantly driven by ...

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...

An overview of the top 10 stories from Optometry Times in 2025.

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

For years, GLP-1 medications like Novo Nordisk's Wegovy and Ozempic have been available only as an injection. Despite the ...

A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...